Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

Table 1 Criteria to include patients in the ESCARVAL-RISK study.

1. Age 30 years or older
2. Free of clinical cardiovascular disease
3. At least one of the following cardiovascular risk factors (as assessed from the most recent data in the clinical record or anthropometry for obesity)
a) Hypertension	- Systolic blood pressure ≥ 140 mm Hg, or
	- Diastolic blood pressure ≥ 90 mm Hg, or
	- Under antihypertensive medication
b) Diabetes mellitus	- Fasting plasma glucose ≥ 7.0 mmol/l (126 mg/dl), or
	- Under antidiabetic medication (insulin or oral medications)
c) Dyslipidaemia	- LDL cholesterol ≥ 4.1 mmol/l (160 mg/dl), or
	- HDL cholesterol < 1.036 mmol/l (40 mg/dl) in men, and < 1.30 mmol/l (50 mg/dl) in women, or
	- Triglycerides ≥ 1.7 mmol/l (150 mg/dl), or
	- Under lipid-lowering medication.
4. Informed consent

ISSN: 1471-2458